99 related articles for article (PubMed ID: 22583357)
21. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.
Kerr A; Eliason JF; Wittliff JL
Adv Exp Med Biol; 2008; 617():377-84. PubMed ID: 18497061
[TBL] [Abstract][Full Text] [Related]
22. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiƶ J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
23. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
[TBL] [Abstract][Full Text] [Related]
25. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
[TBL] [Abstract][Full Text] [Related]
26. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with human small aggressive non small cell lung cancer.
Tammemagi CM; Freedman MT; Church TR; Oken MM; Hocking WG; Kvale PA; Hu P; Riley TL; Ragard LR; Prorok PC; Berg CD
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2082-9. PubMed ID: 17932357
[TBL] [Abstract][Full Text] [Related]
28. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
29. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
30. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
33. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract][Full Text] [Related]
35. Smoking intensity, oxidative stress and chemotherapy in nonsmall cell lung cancer: a correlated prognostic study.
Gupta A; Srivastava S; Prasad R; Natu SM; Mittal B; Negi MP; Srivastava AN
Biosci Trends; 2009 Oct; 3(5):191-9. PubMed ID: 20103846
[TBL] [Abstract][Full Text] [Related]
36. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
37. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
38. [Expression and prognostic value of vacuole membrane protein 1 in non-small-cell lung cancer].
Zhou SQ; Zhou JH; Deng T; Zeng F; Wang YK; Liu XG
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2828-31. PubMed ID: 22333543
[TBL] [Abstract][Full Text] [Related]
39. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
[TBL] [Abstract][Full Text] [Related]
40. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]